Zimmer Biomet announces departure of chief executive officer

Medical Company Restructures

Zimmer Biomet has announced that David Dvorak will be stepping down as president and chief executive officer (CEO), and as a member of the board of directors.

Mr Dvorak has been with the company for 16 years, with ten of those years in the chief executive role. Since joining the firm, its workforce has grown from 3,000 in 2001 to 18,000 in 2017, allowing Zimmer Biomet to become a Fortune 500 company.

“Zimmer Biomet's president and chief executive officer David Dvorak is stepping down, with Daniel Florin to succeed him in an interim role.“

Daniel Florin, the firm's senior vice-president and chief financial officer, has been selected to serve in the additional role of interim CEO until a permanent successor has been named.

A leading executive search firm has been appointed to identify and evaluate candidates for the permanent CEO role.

Larry Glasscock, chairman of the board of Zimmer Biomet, said: "Dan's knowledge of Zimmer Biomet and his achievements here and at other medical device companies make him an excellent choice to support the company through this interim period."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.

See all the latest jobs in Medical Devices
Return to news

Tags